Latest Allotransplantation Stories
HORSHOLM, Denmark, March 13, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced the U.S.
Results provide significant support to advance i-FACTOR(TM) Peptide Enhanced Bone Graft for FDA regulatory review. WESTMINSTER, Colo., March 11, 2014 /PRNewswire/ -- Cerapedics, Inc.,
EDISON, N.J., March 11, 2014 /PRNewswire/ -- The Musculoskeletal Transplant Foundation (MTF), the world's leading tissue bank today announced the recipients of its 2014 Research Grants.
THE COMPANY TO EXHIBIT AT THE AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS (AAOS) MARIETTA, Ga., March 4, 2014 /PRNewswire/ -- MiMedx Group, Inc.
CENTENNIAL, Colo., March 4, 2014 /PRNewswire-USNewswire/ -- AlloSource (allosource.org), one of the nation's largest
LONDON, March 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
CENTENNIAL, Colo., Feb.
MARIETTA, Ga., Feb.
SCOTTSDALE, Ariz., Feb.
Flexible, cancellous bone allografts are used in spine surgery, either alone or as a bone graft extender to stimulate natural bone formation processes MINNEAPOLIS, Feb.
- Growing in low tufty patches.